Vanguard Group Inc Intra Cellular Therapies, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 9,225,981 shares of ITCI stock, worth $668 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,225,981
Previous 9,094,302
1.45%
Holding current value
$668 Million
Previous $651 Million
1.98%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ITCI
# of Institutions
381Shares Held
77.7MCall Options Held
1.7MPut Options Held
1.13M-
Black Rock Inc. New York, NY8.08MShares$585 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$279 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$204 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$179 Million2.06% of portfolio
-
State Street Corp Boston, MA2.24MShares$162 Million0.01% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.84B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...